Abstract
摘要
相似文献
1
[Not Available].[无可用内容]
Rev Med Suisse. 2020 May 13;16(693):1012-1013.
2
Covid-19 in Peru: from supervised walks for children to the first case of Kawasaki-like syndrome.秘鲁的新冠疫情：从儿童的监督下散步到首例川崎病样综合征病例
BMJ. 2020 Jun 22;369:m2418. doi: 10.1136/bmj.m2418.
3
Kawasaki disease epidemic: pitfalls.川崎病流行：陷阱。
Ital J Pediatr. 2020 Aug 27;46(1):121. doi: 10.1186/s13052-020-00887-4.
4
The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children.新型冠状病毒（COVID-19）与儿童川崎病风险
J Formos Med Assoc. 2020 Nov;119(11):1713-1714. doi: 10.1016/j.jfma.2020.05.030. Epub 2020 May 23.
5
Defining Association between COVID-19 and the Multisystem Inflammatory Syndrome in Children through the Pandemic.通过疫情界定新冠病毒疾病（COVID-19）与儿童多系统炎症综合征之间的关联。
J Korean Med Sci. 2020 Jun 8;35(22):e204. doi: 10.3346/jkms.2020.35.e204.
6
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.新冠疫情期间法国疫区出现与 SARS-CoV-2 感染相关的川崎病：时间序列分析。
Lancet Child Adolesc Health. 2020 Sep;4(9):662-668. doi: 10.1016/S2352-4642(20)30175-9. Epub 2020 Jul 2.
7
Rethinking Clinical Trials Reform During the COVID-19 Pandemic.新冠疫情期间对临床试验改革的反思
JAMA Oncol. 2020 Sep 1;6(9):1327-1329. doi: 10.1001/jamaoncol.2020.3142.
8
Disparities in Cancer Outcomes Due to COVID-19-A Tale of 2 Cities.COVID-19导致的癌症治疗结果差异——两个城市的故事
JAMA Oncol. 2020 Oct 1;6(10):1531-1532. doi: 10.1001/jamaoncol.2020.3327.
9
COVID-19 and Kawasaki syndrome: should we really be surprised?新冠病毒与川崎病：我们真的应该感到惊讶吗？
Cardiol Young. 2020 Jul;30(7):1059-1060. doi: 10.1017/S1047951120001432. Epub 2020 Jun 25.
10
Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.COVID-19大流行期间的肿瘤护理服务：研究创新与结果的契机。
JCO Oncol Pract. 2020 Aug;16(8):431-434. doi: 10.1200/OP.20.00326. Epub 2020 May 28.
Zotero 插件